MicroPort Scientific Future Growth
Future criteria checks 1/6
MicroPort Scientific is forecast to grow earnings and revenue by 72.7% and 15.3% per annum respectively. EPS is expected to grow by 72% per annum. Return on equity is forecast to be -19.8% in 3 years.
Key information
72.7%
Earnings growth rate
72.0%
EPS growth rate
| Medical Equipment earnings growth | 14.3% |
| Revenue growth rate | 15.3% |
| Future return on equity | -19.8% |
| Analyst coverage | Good |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,577 | -17 | 165 | 56 | 5 |
| 12/31/2025 | 1,297 | -158 | 108 | -213 | 8 |
| 12/31/2024 | 1,111 | -211 | -173 | -192 | 6 |
| 6/30/2024 | 1,027 | -412 | -269 | -102 | N/A |
| 3/31/2024 | 989 | -445 | -350 | -167 | N/A |
| 12/31/2023 | 951 | -478 | -431 | -232 | N/A |
| 9/30/2023 | 935 | -439 | -513 | -288 | N/A |
| 6/30/2023 | 918 | -401 | -595 | -345 | N/A |
| 3/31/2023 | 880 | -419 | -598 | -344 | N/A |
| 12/31/2022 | 841 | -437 | -601 | -343 | N/A |
| 9/30/2022 | 820 | -410 | -603 | -328 | N/A |
| 6/30/2022 | 799 | -384 | -605 | -313 | N/A |
| 3/31/2022 | 789 | -330 | -555 | -285 | N/A |
| 12/31/2021 | 779 | -276 | -505 | -258 | N/A |
| 9/30/2021 | 753 | -246 | -382 | -198 | N/A |
| 6/30/2021 | 726 | -216 | -260 | -138 | N/A |
| 3/31/2021 | 688 | -204 | -202 | -81 | N/A |
| 12/31/2020 | 649 | -191 | -144 | -23 | N/A |
| 9/30/2020 | 678 | -138 | -119 | 0 | N/A |
| 6/30/2020 | 708 | -85 | -93 | 24 | N/A |
| 3/31/2020 | 751 | -19 | -91 | 25 | N/A |
| 12/31/2019 | 793 | 46 | -89 | 26 | N/A |
| 9/30/2019 | 773 | 56 | -79 | 35 | N/A |
| 6/30/2019 | 752 | 66 | -70 | 44 | N/A |
| 3/31/2019 | 711 | 45 | -38 | 64 | N/A |
| 12/31/2018 | 669 | 24 | -6 | 84 | N/A |
| 9/30/2018 | 603 | 23 | 4 | 95 | N/A |
| 6/30/2018 | 537 | 21 | 13 | 106 | N/A |
| 3/31/2018 | 490 | 20 | N/A | 102 | N/A |
| 12/31/2017 | 444 | 19 | N/A | 97 | N/A |
| 9/30/2017 | 426 | 25 | N/A | 93 | N/A |
| 6/30/2017 | 409 | 31 | N/A | 89 | N/A |
| 3/31/2017 | 399 | 22 | N/A | 86 | N/A |
| 12/31/2016 | 390 | 14 | N/A | 83 | N/A |
| 9/30/2016 | 387 | 5 | N/A | 68 | N/A |
| 6/30/2016 | 383 | -4 | N/A | 54 | N/A |
| 3/31/2016 | 379 | -8 | N/A | 42 | N/A |
| 12/31/2015 | 376 | -12 | N/A | 31 | N/A |
| 9/30/2015 | 369 | -32 | N/A | 29 | N/A |
| 6/30/2015 | 363 | -52 | N/A | 28 | N/A |
| 3/31/2015 | 359 | -56 | N/A | 23 | N/A |
| 12/31/2014 | 355 | -59 | N/A | 18 | N/A |
| 9/30/2014 | 312 | -30 | N/A | 24 | N/A |
| 6/30/2014 | 268 | -1 | N/A | 31 | N/A |
| 3/31/2014 | 210 | 12 | N/A | 44 | N/A |
| 12/31/2013 | 152 | 24 | N/A | 58 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MSK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MSK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MSK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MSK's revenue (15.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: MSK's revenue (15.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MSK is forecast to be unprofitable in 3 years.